Impact of Dose De-Escalation and Escalation on Daptomycin's Pharmacodynamics against Clinical Methicillin-Resistant Staphylococcus aureus Isolates in anIn VitroModel

Prognostic factors in left-sided endocarditis: results from the andalusian multicenter cohort

(2012) Juan Gálvez-Acebal et al.   BMC INFECTIOUS DISEASES

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

(2009) Pamela A Moise et al.   ANNALS OF PHARMACOTHERAPY

Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis

(2009) H. F. Chambers et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations

(2009) S. N. Leonard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital

(2009) Marta Banqué Navarro et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

(2009) et al.   EUROPEAN HEART JOURNAL

Antibiotic stewardship implementation in the EU: the way forward

(2009) Franz Allerberger et al.   Expert Review of Anti-Infective Therapy

High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides

(2009) Mathias Lichterfeld et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides

(2009) S. N. Leonard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic stewardship and consumption: findings from a pan-European hospital study

(2009) J. Bruce et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus

(2009) Soo‐Jin Yang et al.   JOURNAL OF INFECTIOUS DISEASES

Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

(2008) W. E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fatal Bacteremic Mycotic Aneurysm Complicated by Acute Renal Failure Caused by Daptomycin‐Nonsusceptible, Vancomycin‐Intermediate, and Methicillin‐ResistantStaphylococcus aureus

(2008) Chin Chi Kuo et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations

(2008) S. N. Leonard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY